Johnson & Johnson

September 25, 2013

J&J Will Stop Sales of Metal-on-Metal Hip Replacements

As a Texas Metal on Metal hip attorney and medical doctor I am providing this important update to the folks injured by a defective metal hip implant. According to Johnson & Johnson (JNJ), it will stop selling metal-on-metal and ceramic-on-metal hip replacements because of a lower demand for the devices.This decision announcement was made in May 2013.

Metal liners in the Ultamet Metal-on-Metal Articulation and the Complete Ceramic-on-Metal Acetabular Hip System will no longer be available worldwide after August 31. J&J’s DePuy Orthopaedics unit will stop selling related products through 2014 to simplify and streamline its offerings.

Metal on Metal Hip Replacement Sales

September 17, 2013

Dallas, Texas Vaginal Mesh Attorney Warns About Side Effects

by Dr. Shezad Malik

As a Dallas, Texas Trans Vaginal Mesh attorney, I am highlighting this latest research that is putting another nail in the Mesh coffin. According to new published research, transvaginal mesh placement provides no benefits when used for pelvic organ prolapse repair. In a study published in the Obstetrics and Gynecology journal, researchers found that the use of vaginal mesh does not increase good outcome for surgical prolapse repair when compared to more traditional treatments.

Georgetown University researchers halted the study due to the high rate of serious injuries associated with use of vaginal mesh. The study involved 65 women, 33 of whom received vaginal mesh to treat pelvic organ prolapse (POP) and 32 who underwent traditional vaginal prolapse surgery.

The women were followed for three years and the program stopped early because of a 15.6% mesh exposure rate, where the mesh eroded into the vagina.

September 16, 2013

Bard Avaulta Mesh Cases Beginning to Settle

by Dr. Shezad Malik

According to reports, C.R. Bard Inc., has agreed to settle a one of its Avaulta vaginal-mesh implant lawsuits, which allegedly caused severe urinary problems. This case was set for trial this month in New Jersey.

Bard agreed to pay an undisclosed sum to resolve Melanie Virgil’s claims that Bard’s Avaulta Plus insert caused urinary problems. Virgil’s case had been set for a Sept. 23 trial in state court in Atlantic City.

According to the filings, the 56-year-old woman said she needed three surgeries to address urinary problems created by the insert.

September 2, 2013

Bard Settles 2nd Avaulta Transvaginal Mesh Lawsuit

by Dr. Shezad Malik

Recently, Bard settled the second federal Avaulta bellwether trial over its alleged defective transvaginal mesh devices. The settlement was announced by U.S. District Judge Goodwin, who is supervising the transvaginal mesh product liability lawsuits in Charleston, W.Va.

As previously noted, in the first Bard Avaulta bellwether trial, the jury awarded $2 million to a woman who claimed that Bard failed to warn of defects in its product that caused her mesh side effects. The settlement ended the second trial, brought by a North Carolina woman, Wanda Queen. A third bellwether case goes to trial on October 8 and a fourth on November 4.

Over 20,000 Trans Vaginal Mesh Lawsuits Pending

August 20, 2013

Bard Avaulta Vaginal Mesh Trial $2M Plaintiff’s Verdict

by Dr. Shezad Malik

Last week, a federal jury in West Virginia awarded $2 million in damages in a Bard Avaulta vaginal mesh defective product liability claim. The verdict included punitive damages to punish CR Bard Inc., the manufacturer for selling a defective product that has been linked to severe internal injuries.

This is the first federal Vaginal Mesh verdict, in more than 25,000 vaginal mesh lawsuits pending in the federal court system.

Plaintiff Suffered Serious Injuries

July 31, 2013

Tylenol Bad for the Liver

by Dr. Shezad Malik

In April, the U.S. Judicial Panel on Multidistrict Litigation consolidated all product liability lawsuits involving Tylenol. Plaintiffs allege that Johnson & Johnson failed to adequately warn about the risk of liver failure or liver damage from Tylenol. These Tylenol federal lawsuits are centralized before U.S. District Judge Lawrence F. Stengel in the Eastern District of Pennsylvania.

What is the problem with Tylenol?

Tylenol is a blockbuster medication, used for pain relief, that is available over the counter. Tylenol been used by millions of American adults and children. Tylenol the trade name, contains acetaminophen as the active pharmaceutical ingredient.

July 18, 2013

Bard Avaulta Mesh Trial Ends Abruptly

by Dr. Shezad Malik

U.S. District Judge Joseph Goodwin presiding over the first federal Bard Mesh trial has declared a mistrial. This trial involved complications associated with Bard Avaulta mesh. On the second day of trial, a gynecological expert mentioned that the Bard Avaulta mesh has been removed from the market. In pre-trial rulings, the parties agreed that evidence of the products subsequent withdrawal would be excluded because it may bias the jury.

What is Bard Avaulta Mesh?

Bard Avaulta mesh is used for transvaginal surgical repair of pelvic organ prolapse (POP) and female stress urinary incontinence (SUI). Thousands of women have claimed that Avaulta plastic mesh have caused them to suffer serious and catatrophic injuries when the mesh may eroded through the vagina.

July 17, 2013

Federal DePuy ASR Trial Set For September

by Dr. Shezad Malik

A New York woman, Ann McCracken’s defective hip claim will be the first DePuy ASR hip lawsuit to go to trial in federal court. McCracken’s case is a “bellwether” case, designed to determine how juries will respond to presented evidence and testimony.

7,800 Federal DePuy ASR Lawsuits

More than 7,800 lawsuits have been brought in the federal court system by folks who have problems with the recalled DePuy ASR hip implant. These metal on metal hip cases are consolidated as part of an MDL, or Multidistrict Litigation, which is centralized before U.S. District Judge Katz in the Northern District of Ohio.